Sirolimus as a second-line treatment for Graves' orbitopathy.
J Endocrinol Invest
; 45(11): 2171-2180, 2022 Nov.
Article
in En
| MEDLINE
| ID: mdl-35831587
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Exophthalmos
/
Graves Ophthalmopathy
Type of study:
Clinical_trials
/
Observational_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
J Endocrinol Invest
Year:
2022
Document type:
Article
Affiliation country:
Italy